Pantoprazole Sodium 40mg Delayed-Release Tablets

These are oral delayed-release tablets containing 40mg of pantoprazole sodium, a proton pump inhibitor used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. They fall under HTS 3004.90.92.55 as unmixed medicaments put up in measured doses for retail sale, primarily affecting the digestive system via pantoprazole or its salts.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

2933.39.21Higher: 6.5% vs Free

If imported in bulk powder form without measured doses

Bulk pantoprazole sodium as a heterocyclic compound falls under Chapter 29 chemicals, not finished medicaments.

3004.90Same rate: Free

If primarily affecting a different system, like omeprazole-based

Other digestive medicaments not specified as pantoprazole go to broader 3004.90.91 subheading.

3003.39Higher: 10% vs Free

If sold as part of a multi-ingredient mixed formulation

Medicaments in measured doses with mixed active ingredients classify under Chapter 30 heading 3003 for mixtures.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Verify pantoprazole content via certificate of analysis to confirm classification under 3004.90.92.55; mislabeling risks reclassification

Ensure FDA registration and NDC labeling for retail packs; provide stability data for delayed-release formulations

Avoid bulk shipments without measured doses, as they may shift to unmixed chemical headings like 2933

Related Products under HTS 3004.90.92.55